Applied DNA Sciences, Inc. (BNBX)

Market Cap	6.01M
Revenue (ttm)	3.74M
Net Income (ttm)	40.68M
Shares Out	1.29M
EPS (ttm)	211.51
PE Ratio	0.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	515,906
Open	5.830
Previous Close	n/a
Day's Range	4.230 - 5.850
52-Week Range	2.130 - 327.319
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 18, 2025

About BNBX

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-base...

• Founded: 1983
• Employees: 48
• Stock Exchange: NASDAQ
• Ticker Symbol: BNBX
• Website: https://www.adnas.com

Financial Performance

In 2024, Applied DNA Sciences's revenue was $3.43 million, a decrease of -74.33% compared to the previous year's $13.37 million. Losses were -$7.23 million, -27.36% less than in 2023.